IceCure Medical (ICCM) Raw Materials (2020 - 2025)

IceCure Medical (ICCM) has reported Raw Materials for 6 consecutive years, with $1.8 million the latest figure, recorded in Q4 2025.

• On a quarterly basis, Raw Materials rose 28.2% year-over-year to $1.8 million in Q4 2025; TTM through Dec 2025 was $1.8 million, a 28.2% increase from a year earlier, with the FY2025 full-year figure at $1.8 million, up 28.2% from the prior year.
• Raw Materials was $1.8 million for Q4 2025 at IceCure Medical, up from $1.4 million in the prior quarter.
• Over five years, Raw Materials peaked at $1.8 million in Q4 2025 and troughed at $704000.0 in Q4 2021.
• A 5-year average of $1.4 million and a median of $1.4 million in 2024 frame the typical range for Raw Materials.
• Across the five-year window, Raw Materials soared 122.44% in 2022 and decreased 11.17% in 2023, its largest moves.
• Over 5 years, Raw Materials stood at $704000.0 in 2021, then surged by 122.44% to $1.6 million in 2022, then declined by 11.17% to $1.4 million in 2023, then increased by 1.22% to $1.4 million in 2024, then gained by 28.2% to $1.8 million in 2025.
• The last three Raw Materials figures came in at $1.8 million (Q4 2025), $1.4 million (Q4 2024), and $1.4 million (Q4 2023), per Business Quant data.